Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysisVíctor Sapena, María Reig, Rosanna Villani et al.|Gut|2021Cited by 96
First-Line Immune Checkpoint Inhibitor-Based Sequential Therapies for Advanced Hepatocellular Carcinoma: Rationale for Future TrialsGiuseppe Cabibbo, Calogero Cammà, Amit G. Singal et al.|Liver Cancer|2021Cited by 50
Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular CarcinomaGiuseppe Cabibbo, Calogero Cammà, María Reig et al.|Cancers|2020Cited by 34